Moving Life Science Innovations along the path
From Discovery To Development To Delivery
OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.
OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.
Arizona’s bioscience industry employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. Academic R&D expenditures in bioscience fields reached a new height of $683.3 million in 2022. NIH funding for Arizona totaled $366.5 million in 2023 following steady annual growth since 2019. Arizona’s bioscience companies attracted strong venture capital investment, with $281.8 million invested in 2023. Arizona stands out in patent activity in bioscience-related technology areas—its 3,387 patent awards from 2019 through 2023 places the state in the second quintile among all states. AZ-BIO2024 - state profile
IN THE LOOP
AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.
SubscribeAZBio Members Are Making LIFE Better
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.
AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.
AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.
Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.
Success Stories – Good News from Arizona’s BioIndustry
Your Opportunity to Explore Evolutionary Cell Biology
Evolutionary Cell Biology is a new emerging subdiscipline that strives to integrate the fields of cell biology, biophysics, bioenergetics, and evolutionary theory in novel ways, in an attempt to develop a more comprehensive field of evolutionary biology focused at the mechanistic level. Thanks to a grant from the National Science Foundation, the public can listen […]
ASPIRO THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE™ 2025
Pioneering a Novel Disease-Modifying Therapy for Obstructive Lung Disease
Introducing Investor Corner PBC: A New Hub for Investor-Company Connections
PHOENIX, AZ (January 8, 2025) – The Phoenix Bioscience Core (PBC) is proud to announce the launch of Investor Corner PBC — a dedicated space for investors to connect with innovators, entrepreneurs, and changemakers in the heart of Arizona’s bioscience ecosystem.
CEI Announces Program to Help Startups Raise Capital
Securing capital for your startup can seem daunting to entrepreneurs, but with the right strategies, resources, and expert guidance, it’s entirely within reach. The Center for Entrepreneurial Innovation (CEI) has introduced Capital Cure, a 16-week course designed to guide you through the entire capital-raising process. Whether preparing for your first funding round or gearing up for […]
Events
- 2025 State Bio Friends Reception
Jan 12, 2025 - San Francisco - Biotech Showcase 2025
Jan 13, 2025 - San Francisco - RESI JPM 2025
Jan 14, 2025 - San Francisco - AZBio 2025 Kickoff Reception at Mayo Clinic
Jan 23, 2025 - - AZBioPEERS: Insights from JPM 2025
Jan 28, 2025 -